Per Rehné, CEO at Clasado, has offered his thoughts on the global prebiotic market
Clasado Biosciences has commented on the prebiotics market and the “enormous growth potential ahead”.
The business has shared insight on increasing consumer awareness of the benefits of prebiotics and the upswing in demand from key players in the health and nutrition categories.
Per Rehné, CEO at Clasado, said: “Consumers are now better connected with their physical health – now being proactive more than reactive. It’s really no surprise that gut health is surging to the top of the public agenda. The inclusion of prebiotic ingredients in a wide range of foods and supplements is on the up and will only accelerate from this point. All signs point to exponential growth for the prebiotics market and significant opportunities for brands.
“Because the prebiotic market has gathered pace over a relatively short space of time, it’s easy to forget that the isolated prebiotic ingredients are still relatively new compared to many of today’s nutrition technologies. Global Market Insights predicts a very solid 8.5% global CAGR for prebiotics until 2024, but by all accounts, it is likely to surpass this. This acceleration is a perfect example of ‘the right technology, connecting with the right market, at the right time’. It’s no wonder multinational brands are taking a closer look at the commercial potential of a scientifically backed GOS ingredient like Bimuno.”
Rehné continued: “There is real market appetite and we’re seeing this reflected in new product innovation from some of the biggest international brands. For example, we are currently working on a major project with global consumer goods giant Procter & Gamble. The launch will see Bimuno feature heavily in a novel gummy designed to make a real difference to the consumer. It marks the first time our established prebiotic ingredient has been used in this particular format, and we look forward to sharing further details in the near future. Prebiotics are now clearly shifting into the mainstream and creating tremendous opportunities for added value consumer health and nutrition products.”
Bimuno, a proprietary ingredient available in powder or syrup form, is supported by 90 scientific publications, Clasado claims, including more than 20 clinical trials. Clasado partners with brands to integrate Bimuno into product ranges with the aim to enhance health benefits and accelerate consumer appeal.
Rehné concluded: “As well as an impressively low effective dose, Bimuno is extremely stable, which makes it easy to fit into different delivery methods. Ideal for standalone supplements and pastilles, Bimuno is also used in the creation of gut-health focused functional foods, many of which are relatively untapped markets. There’s prime opportunity for brands in baked goods, snacks and dairy to be the first to market. Interestingly, we are also seeing a rapid upswing in prebiotics delivered in a gummy format.
“It’s an exciting time for brand owners and formulators. We’re only just scratching the surface of what prebiotics are capable of in terms of capturing consumer attention and unlocking fundamentally better gut health.”